(Press-News.org) NIH grants support UCLA and Charles Drew University researchers' efforts to end HIV epidemic
The National Institutes of Health (NIH) has granted $2.1 million to UCLA’s Center for HIV Identification, Prevention, and Treatment Services (CHIPTS) and the UCLA-CDU Center for AIDS Research (CFAR) to support four research projects and an implementation science consultation hub. These awards will fund projects to strengthen research-community collaborations and enhance implementation strategies needed for the Ending the HIV Epidemic in the U.S. (EHE) initiative.
“These awards will support our scientists and community partners to address the systemic factors impacting our most vulnerable populations and explore innovative implementation strategies to help end the HIV epidemic,” said Steve Shoptaw, CHIPTS director and professor of family medicine at the David Geffen School of Medicine at UCLA. “We also look forward to continuing to support the research priorities of the EHE initiative through our Implementation Science Hub.”
Funded projects include:
Advancing HIV Implementation Research (Implementation Science Consultation Hub)
Implementation science plays an important role in the advancement of HIV research. The field recognizes that healthcare systems, public health agencies and communities often struggle to provide high quality services with limited resources. Alison Hamilton, professor-in-residence of psychiatry and biobehavioral sciences at UCLA’s Semel Institute for Neuroscience and Human Behavior and chief officer of implementation and policy at the VA Center for the Study of Healthcare Innovation, Implementation & Policy at Greater Los Angeles Healthcare System, will lead the UCLA Rapid, Rigorous, Relevant Implementation Science Hub, which will offer tailored coaching, training, and technical assistance to NIH-supported implementation research projects across the U.S. in efforts to end the HIV epidemic .
Addressing HIV Risk Among Vulnerable Youth
Dallas Swendeman, associate professor in the Division of Health Promotion and Behavioral Science in the School of Public Health at San Diego State University and a licensed clinical psychologist, will lead a project that explores strategies to support the implementation of an intervention to reduce HIV risk among sexual and gender minority and racial/ethnic minority youth aged 12 to 24. These groups face disproportionate risk of acquiring HIV due to various factors, including low uptake of pre-exposure prophylaxis (PrEP), yet effective and scalable interventions for youth remain limited. This study will accelerate implementation of the Adolescent HIV Medicine Trials Network (ATN) Protocol 149 Optimizing the HIV Prevention Continuum for Youth. The researchers will collaborate with community partners to explore implementation strategies for this intervention and prepare for application in real-world settings.
Enhancing HIV Prevention for Transgender and Nonbinary Individuals
Erik Storholm, professor of psychiatry and biobehavioral sciences at the Semel Institute, will lead a project to address low PrEP uptake and persistence among transgender and nonbinary individuals (TGNB) at-risk of HIV in Los Angeles County. Multiple syndemic barriers have been found to contribute to low PrEP uptake and persistence among TGNB individuals, such as intimate partner violence (IPV) and mental health burdens. This project will assess implementation outcomes and preliminary effects of integrating IPV prevention and mental health services into an ongoing gender-affirming PrEP program at a Los Angeles-based trans community center.
Reducing Barriers to HIV Prevention and Treatment among Black Americans
Black Americans are disproportionately affected by HIV, particularly young Black sexual minority men. Laura Bogart, professor-in-residence of psychiatry and biobehavioral sciences at the Semel Institute and chief officer of implementation and policy at the VA Center for the Study of Healthcare Innovation, Implementation & Policy at Greater Los Angeles Healthcare System will lead a study to enhance the implementation strategies and create a sero-status neutral version of the Rise intervention, a culturally tailored program to address adherence and retention barriers among Black individuals with HIV. Rise intervention, built on a 17-year community-academic partnership, will be expanded and tailored to address PrEP and antiretroviral therapy (ART) uptake and adherence among Black Americans in Los Angeles County and in Jefferson County, Alabama.
Improving PrEP Access for Black, Latino Sexual Minority Men and People who Inject Drugs
Dr. Gabriel Edwards, associate project scientist at the Geffen School, aims to bridge disparities in PrEP uptake among Black and Latino sexual minority men and people who inject drugs. The study will partner with the Los Angeles Centers for Alcohol and Drug Abuse (L.A. CADA) to provide community outreach to expand HIV testing and linkage with PrEP navigators to help facilitate PrEP medication access. The study will identify factors affecting successful linkages to PrEP in order to develop recommendations for improvement.
“Taken together, these awards reflect UCLA’s and CDU’s commitment to ending the HIV epidemic through innovative and community-focused approaches by focusing on populations most impacted by HIV and addressing the systemic barriers that put these populations at risk,” said LaShonda Spencer, director of Drew CARES and professor of pediatrics and internal medicine at Charles R. Drew University of Medicine and Science.
END
NIH grants support UCLA and Charles Drew University researchers' efforts to end HIV epidemic
2023-11-02
ELSE PRESS RELEASES FROM THIS DATE:
AI trained to identify least green homes by Cambridge researchers
2023-11-02
University of Cambridge media release
First of its kind AI-model can help policy-makers efficiently identify and prioritize houses for retrofitting and other decarbonizing measures.
FOR IMMEDIATE RELEASE
Model identified ‘hard to decarbonize’ houses with 90% precision and additional data will improve this.
Model trained with open source data including from energy performance certificates, and street and aerial view images. It could be used anywhere in the world.
Model can even identify specific parts of houses losing most heat, including roofs and windows.
‘Hard-to-decarbonize’ (HtD) houses are responsible ...
EU MiFID II unbundling rules damaged research and liquidity in London’s main stock market – new study
2023-11-02
New research from the University of Bath shows the European Union’s MiFID II financial market reforms inadvertently reduced research activity and adversely affected liquidity in London’s main stock market but that the impact on London’s less regulated Alternative Investment Market was mitigated by its special adviser rules.
The EU’s Markets in Financial Instruments Directive II (MiFID II) from 2018 aimed to improve transparency around research costs, which were previously bundled into brokers’ overall fees to clients. The legislation demanded the fees be ‘unbundled’ to make the hidden costs more explicit ...
International study led by researchers in Singapore reveals critical insights into timely interventions for maternal depression
2023-11-02
SINGAPORE – A large-scale international study spanning three continents, led by researchers from A*STAR’s Translational Neuroscience Programme of the Singapore Institute for Clinical Sciences (SICS) in Singapore, has found that maternal depressive symptoms begin from early pregnancy and can last up to two years after childbirth.
While health professionals often emphasise the postpartum stage after childbirth as a high-risk period for the onset of depression, findings from this latest study reveal a different reality – that maternal depressive symptoms can appear from early pregnancy ...
Paper argues reducing greenhouse gas emissions is not enough to combat climate change
2023-11-02
According to a new paper in Oxford Open Climate Change, published by Oxford University Press, the strategies humanity must pursue to reduce climate change will have to include more than reducing greenhouse gases. This comes from an analysis of climate data led by researcher James Hansen.
Scientists have known since the 1800s that infrared-absorbing (greenhouse) gases warm the Earth’s surface and that the abundance of greenhouse gases changes naturally as well as from human actions. Roger Revelle, who was one of the early scientists to study global warming, wrote in 1965 that industrialization meant that human ...
Research examines why mask usage in Japan persists
2023-11-02
Osaka, Japan – When you think of Japan in the age of COVID, you might imagine a crowd of people wearing masks. But why do so many Japanese people wear masks?
In an article published this month in the International Journal of Disaster Risk Reduction, a researcher from Osaka University analyzed mask use before and after the government of Japan downgraded the legal status of COVID-19. Results showed that many people continue to wear masks for socio-psychological reasons – including reasons related to ‘relief’ and ‘norm’.
Of course, the obvious motivation for mask use is disease prevention. In the first ...
Exercise therapy based on smart data to improve patients' quality of life
2023-11-02
Regular and moderate physical activity can significantly improve the quality of life of people with internal diseases such as cancer and depression. Unfortunately, many people with internal disorders cannot sufficiently participate in exercise training for several reasons. For example, they often do not have access to appropriate exercise training programs, have a high therapeutic burden, fatigue, or simply no time to engage in physical activity. Accordingly, the Sports Medicine research group led by Professor Perikles Simon at Johannes Gutenberg University Mainz (JGU) investigates how physical activity can be promoted and integrated into patients' daily lives by applying digital tools ...
Alternative antibiotic selection can reduce the risk of healthcare-associated infections for patients with pneumonia
2023-11-02
Arlington, Va. — November 2, 2023 — A new study published today in the American Journal of Infection Control (AJIC) reveals that the use of doxycycline may help protect against Clostridioides difficile (C. diff) infection for some patients with pneumonia. Specifically, study authors found that for hospitalized patients with community-acquired pneumonia who had experienced C. diff infections in the prior year, the use of doxycycline, instead of the more commonly used azithromycin, reduced the development ...
Survey finds most Americans are unaware of many signs that someone is having a seizure
2023-11-02
Orlando, Fla - If you’ve ever seen a movie or TV show in which a character has a seizure, you probably have a fairly standard mental picture of someone falling to the ground in full body convulsions while foaming at the mouth. But that doesn’t necessarily reflect reality. A new national survey by Orlando Health finds that while most Americans recognize those classic symptoms of what’s called a generalized tonic-clonic seizure, the majority fail to recognize the subtle signs, all of which can be dangerous and have a profound ...
A “manganese bullet” targeting the top killer?
2023-11-02
Cardiovascular diseases (CVDs) continue to rank as the top killer in the modern world. This deadly disorder often starts with the buildup of lipid deposits or plaques within the blood vessel, silently setting the stage for atherosclerosis. Rupture of these atherosclerotic plaques, however, could clot blood vessels and lead to life-threatening conditions including heart attack or stroke.
Dyslipidemia, meaning having too much “bad” or atherogenic lipids in the blood, represents the most common cause of CVDs and ...
New NUS study provides insights into early breast cancer development in individuals with BRCA2 mutations
2023-11-02
A pioneering study led by Professor Ashok Venkitaraman from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore and Dr Mona Shehata from the University of Cambridge (UK) has uncovered vital insights into the distinct effects of BRCA2 mutations on breast tissue cells, shedding light on early breast cancer development in people with BRCA2 mutations. The research was published in the prestigious journal Nature Communications on 25 August 2023.
Breast cancer is a serious concern for individuals with BRCA2 mutations, ...